I

iCAD
D

ICAD

3.68500
USD
-0.13
(-3.28%)
Market Closed
Volume
15,244
EPS
-0
Div Yield
-
P/E
-19
Market Cap
100,453,240
Related Instruments
AAPL
AAPL
4.660
(2.37%)
200.920 USD
AMD
AMD
1.450
(1.14%)
128.230 USD
CRM
CRM
1.15
(0.44%)
260.64 USD
GOOGL
GOOGL
-6.600
(-3.81%)
166.690 USD
IBM
IBM
-2.30
(-0.81%)
280.97 USD
INTC
INTC
-0.415
(-1.93%)
21.065 USD
MSFT
MSFT
-2.96
(-0.62%)
477.27 USD
NVDA
NVDA
-1.700
(-1.17%)
143.770 USD
ORCL
ORCL
-5.520
(-2.62%)
205.180 USD
SAP
SAP
-2.17
(-0.75%)
287.66 USD
More
News

Title: iCAD

Sector: Healthcare
Industry: Medical Devices
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging andComputed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.